These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 108205)

  • 41. Cytostasis against self-antigens.
    De Giorgi L; Matossian-Rogers A; Festenstein H
    Clin Exp Immunol; 1978 Feb; 31(2):209-17. PubMed ID: 77201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of homology in the JC subregion of the H2 complex in the reciprocal suppression of normal killer and tumor cells].
    Zedginidze MS; Spirande IV; Nikonenko BV; Fuks BB
    Biull Eksp Biol Med; 1982 Apr; 93(4):82-5. PubMed ID: 7082810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
    Maier T; Holda JH
    J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.
    Schirrmacher V
    Int J Cancer; 1979 Jul; 24(1):80-6. PubMed ID: 314423
    [No Abstract]   [Full Text] [Related]  

  • 45. Interacting genetic factors controlling the antibody response against the H-2.2 specificity.
    Decoville M; Motta R
    Immunogenetics; 1982 Mar; 15(3):279-85. PubMed ID: 6802752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of non-H-2 genes in the control of the in vivo growth of the virus induced lymphoma YC8.
    Colombo MP; Parmiani G
    J Immunogenet; 1981 Oct; 8(5):405-13. PubMed ID: 6795282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. H-21-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells.
    Lonai P; Katz E; Peled A; Haran-Ghera N
    Immunogenetics; 1981 Mar; 12(5-6):423-32. PubMed ID: 6260638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of patterns of hybrid resistance to the BALB/c plasmacytomas LPC-1 and MPC-11.
    Walker MC; Phillips-Quagliata JM
    Cancer Immunol Immunother; 1985; 20(1):47-54. PubMed ID: 3851694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological characteristics of leukemia and lymphoma in allogeneic cell immunity: growth of syngeneic tumors in rats immunized with allogeneic cells.
    Hosokawa M; Yamashita T; Gotohda E; Takeichi N; Kodama T; Kobayashi H
    Int J Cancer; 1978 Jul; 22(1):91-7. PubMed ID: 681026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo and in vitro analyses of the immunogenicity of B16 melanoma cells.
    Heath W; Boyle W
    Aust J Exp Biol Med Sci; 1985 Apr; 63 ( Pt 2)():163-75. PubMed ID: 3876093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new erythrocytic antigen of C57BL/10 (B10) mice.
    Walker MC; Phillips-Quagliata JM
    Proc Soc Exp Biol Med; 1985 Mar; 178(3):402-6. PubMed ID: 3975228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic control of the production of anti-thyroid hormone antibodies in mice immunized with human thyroglobulin.
    Sakata S; Okuda K; Aihara Y; Tanaka Y; Nakamura S; Komaki T; Tarutani O; Miura K
    Immunol Invest; 1986 Aug; 15(5):481-92. PubMed ID: 3096882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel H-2s class I molecule expressed on a B-cell leukemia from SJL/J mice.
    Siwarski DF; Prat M; Rogers MJ
    Mol Immunol; 1985 Aug; 22(8):961-6. PubMed ID: 2413349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic control of humoral immunity to sperm acrosomal and cell surface antigens.
    Tarter TH; Alexander NJ
    J Reprod Immunol; 1984 Jul; 6(4):213-26. PubMed ID: 6438308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-IA alloantisera.
    Perry LL; Dorf ME; Benacerraf B; Greene MI
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):920-4. PubMed ID: 106399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunosurveillance of spontaneous lung adenomagenesis in mice.
    Colnaghi MI
    Eur J Cancer (1965); 1975 Sep; 11(9):633-7. PubMed ID: 767117
    [No Abstract]   [Full Text] [Related]  

  • 57. Multicellular tumour spheroids: a model for combined in vivo/in vitro assay of tumour immunity.
    Culo F; Yuhas JM; Ladman AJ
    Br J Cancer; 1980 Jan; 41(1):100-12. PubMed ID: 7362771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic differences in F1 hybrid resistance against tumours of the same parental strain. I. Tumours of C57Bl/6 origin.
    Klein GO; Klein G
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):731-42. PubMed ID: 6800800
    [No Abstract]   [Full Text] [Related]  

  • 59. Study of host immunological resistance to syngeneic lymphoma using whole body irradiation.
    Maruyama Y
    Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1159-69. PubMed ID: 993092
    [No Abstract]   [Full Text] [Related]  

  • 60. The role of H-2 and H-2-like determinants in syngeneic and allogeneic cytostasis.
    De Giorgi L; Biasi G; Festenstein H
    J Immunogenet; 1978 Feb; 5(1):49-57. PubMed ID: 76664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.